Immunovant, Inc. - COM (IMVT)

Historical Portfolio Holders from Q4 2019 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
68.6 M
Holdings value Q1 2024
$2.22 B
Value change Q1 2024
-$5.09 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
200
Number of buys Q1 2024
105
Number of sells Q1 2024
-123
Average buys Q1 2024 %
+0.004%
Average sells Q1 2024 %
-0.003%
CUSIP
45258J102
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 68.6 M $2.22 B -$5.09 M $32.31 200
2023 Q4 67.8 M $2.86 B +$4.85 M $42.13 228
2023 Q3 67.8 M $2.6 B +$461 M $38.39 185
2023 Q2 55.4 M $1.05 B -$33.1 M $18.97 148
2023 Q1 58.3 M $904 M +$20.9 M $15.51 141
2022 Q4 55.3 M $981 M +$239 M $17.75 131
2022 Q3 42.5 M $237 M +$14.2 M $5.58 105
2022 Q2 39.4 M $154 M +$1.51 M $3.90 86
2022 Q1 38.9 M $214 M +$6.84 M $5.51 104
2021 Q4 37.7 M $321 M -$4.3 M $8.52 117
2021 Q3 33.8 M $294 M -$49.3 M $8.69 120
2021 Q2 38.5 M $407 M -$67.5 M $10.57 115
2021 Q1 40.2 M $645 M -$273 M $16.04 120
2020 Q4 40.3 M $1.86 B +$40 M $46.19 145
2020 Q3 39.8 M $1.4 B +$384 M $35.19 113
2020 Q2 28.6 M $696 M +$385 M $24.35 87
2020 Q1 12.6 M $194 M +$15.2 M $15.56 41
2019 Q4 11 M $171 M +$158 M $15.87 23